Artal Group’s Sana Biotechnology SANA Stock Holding History

Artal Group’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-400,000	Closed	-$2.38M	–	117
2023 Q2	$2.38M	Hold	400,000	–	–	0.07%	82
2023 Q1	$1.31M	Hold	400,000	–	–	0.08%	89
2022 Q4	$1.58M	Hold	400,000	–	–	0.09%	96
2022 Q3	$2.4M	Hold	400,000	–	–	0.1%	84
2022 Q2	$2.57M	Hold	400,000	–	–	0.14%	87
2022 Q1	$3.3M	Hold	400,000	–	–	0.14%	98
2021 Q4	$6.19M	Hold	400,000	–	–	0.17%	91
2021 Q3	$9.01M	Hold	400,000	–	–	0.2%	84
2021 Q2	$7.86M	Hold	400,000	–	–	0.16%	102
2021 Q1	$13.4M	Buy	+400,000	New	+$13M	0.24%	83

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Artal Group's SANA Position: Q3 2023 in Review

Artal Group sold out of Sana Biotechnology (SANA) in Q3 2023, closing a stake of 400,000 shares — an estimated $2.38M sold.

Artal Group first reported a position in SANA in Q1 2021 and held it in 10 quarters. The position peaked at $13.4M in Q1 2021. 136 funds tracked by Wall St. Rank hold SANA as of Q3 2023.

Artal Group reported no remaining Sana Biotechnology position as of Q3 2023 after selling out during the quarter.
Artal Group sold 400,000 Sana Biotechnology shares in Q3 2023, an estimated $2.38M.
Artal Group first reported a position in Sana Biotechnology in Q1 2021 and held it in 10 quarters.
Artal Group's Sana Biotechnology position peaked at $13.4M in Q1 2021.
136 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2023.

Based on Artal Group's 13F filing for Q3 2023, filed 13 Nov 2023.